DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?
Identifieur interne :
002F25 ( PascalFrancis/Corpus );
précédent :
002F24;
suivant :
002F26
DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?
Auteurs : A. E. Kingsbury ;
C. D. Mardsen ;
O. J. F. FosterSource :
-
Movement disorders [ 0885-3185 ] ; 1998.
RBID : Pascal:99-0011802
Descripteurs français
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 13 |
---|
A06 | | | | @2 6 |
---|
A08 | 01 | 1 | ENG | @1 DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect? |
---|
A11 | 01 | 1 | | @1 KINGSBURY (A. E.) |
---|
A11 | 02 | 1 | | @1 MARDSEN (C. D.) |
---|
A11 | 03 | 1 | | @1 FOSTER (O. J. F.) |
---|
A14 | 01 | | | @1 Parkinson's Disease Society Brain Research Centre, Institute of Neurology @2 London @3 GBR @Z 1 aut. @Z 3 aut. |
---|
A14 | 02 | | | @1 Institute of Neurology, The National Hospital @2 London @3 GBR @Z 2 aut. |
---|
A14 | 03 | | | @1 St. George's Hospital Medical School @2 London @3 GBR @Z 3 aut. |
---|
A20 | | | | @1 877-884 |
---|
A21 | | | | @1 1998 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000071406360030 |
---|
A44 | | | | @0 0000 @1 © 1999 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 32 ref. |
---|
A47 | 01 | 1 | | @0 99-0011802 |
---|
A60 | | | | @1 P |
---|
A61 | | | | @0 A |
---|
A64 | | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B17G |
---|
C03 | 01 | X | FRE | @0 Parkinson maladie @5 01 |
---|
C03 | 01 | X | ENG | @0 Parkinson disease @5 01 |
---|
C03 | 01 | X | SPA | @0 Parkinson enfermedad @5 01 |
---|
C03 | 02 | X | FRE | @0 Substance grise @5 04 |
---|
C03 | 02 | X | ENG | @0 Grey matter @5 04 |
---|
C03 | 02 | X | SPA | @0 Substancia gris @5 04 |
---|
C03 | 03 | X | FRE | @0 Fragmentation @5 07 |
---|
C03 | 03 | X | ENG | @0 Fragmentation @5 07 |
---|
C03 | 03 | X | SPA | @0 Fragmentación @5 07 |
---|
C03 | 04 | X | FRE | @0 DNA @5 08 |
---|
C03 | 04 | X | ENG | @0 DNA @5 08 |
---|
C03 | 04 | X | SPA | @0 DNA @5 08 |
---|
C03 | 05 | X | FRE | @0 Apoptose @5 10 |
---|
C03 | 05 | X | ENG | @0 Apoptosis @5 10 |
---|
C03 | 05 | X | SPA | @0 Apoptosis @5 10 |
---|
C03 | 06 | X | FRE | @0 Postmortem @5 16 |
---|
C03 | 06 | X | ENG | @0 Postmortem @5 16 |
---|
C03 | 06 | X | SPA | @0 Postmortem @5 16 |
---|
C03 | 07 | X | FRE | @0 Exploration @5 17 |
---|
C03 | 07 | X | ENG | @0 Exploration @5 17 |
---|
C03 | 07 | X | SPA | @0 Exploración @5 17 |
---|
C03 | 08 | X | FRE | @0 Homme @5 20 |
---|
C03 | 08 | X | ENG | @0 Human @5 20 |
---|
C03 | 08 | X | SPA | @0 Hombre @5 20 |
---|
C03 | 09 | X | FRE | @0 In situ @5 23 |
---|
C03 | 09 | X | ENG | @0 In situ @5 23 |
---|
C03 | 09 | X | SPA | @0 In situ @5 23 |
---|
C07 | 01 | X | FRE | @0 Système nerveux pathologie @5 37 |
---|
C07 | 01 | X | ENG | @0 Nervous system diseases @5 37 |
---|
C07 | 01 | X | SPA | @0 Sistema nervioso patología @5 37 |
---|
C07 | 02 | X | FRE | @0 Système nerveux central pathologie @5 38 |
---|
C07 | 02 | X | ENG | @0 Central nervous system disease @5 38 |
---|
C07 | 02 | X | SPA | @0 Sistema nervosio central patología @5 38 |
---|
C07 | 03 | X | FRE | @0 Encéphale pathologie @5 39 |
---|
C07 | 03 | X | ENG | @0 Cerebral disorder @5 39 |
---|
C07 | 03 | X | SPA | @0 Encéfalo patología @5 39 |
---|
C07 | 04 | X | FRE | @0 Extrapyramidal syndrome @5 40 |
---|
C07 | 04 | X | ENG | @0 Extrapyramidal syndrome @5 40 |
---|
C07 | 04 | X | SPA | @0 Extrapiramidal síndrome @5 40 |
---|
C07 | 05 | X | FRE | @0 Maladie dégénérative @5 41 |
---|
C07 | 05 | X | ENG | @0 Degenerative disease @5 41 |
---|
C07 | 05 | X | SPA | @0 Enfermedad degenerativa @5 41 |
---|
C07 | 06 | X | FRE | @0 Encéphale @5 45 |
---|
C07 | 06 | X | ENG | @0 Brain (vertebrata) @5 45 |
---|
C07 | 06 | X | SPA | @0 Encéfalo @5 45 |
---|
N21 | | | | @1 004 |
---|
|
Format Inist (serveur)
NO : | PASCAL 99-0011802 INIST |
ET : | DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect? |
AU : | KINGSBURY (A. E.); MARDSEN (C. D.); FOSTER (O. J. F.) |
AF : | Parkinson's Disease Society Brain Research Centre, Institute of Neurology/London/Royaume-Uni (1 aut., 3 aut.); Institute of Neurology, The National Hospital/London/Royaume-Uni (2 aut.); St. George's Hospital Medical School/London/Royaume-Uni (3 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 6; Pp. 877-884; Bibl. 32 ref. |
LA : | Anglais |
CC : | 002B17G |
FD : | Parkinson maladie; Substance grise; Fragmentation; DNA; Apoptose; Postmortem; Exploration; Homme; In situ |
FG : | Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Encéphale |
ED : | Parkinson disease; Grey matter; Fragmentation; DNA; Apoptosis; Postmortem; Exploration; Human; In situ |
EG : | Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Brain (vertebrata) |
SD : | Parkinson enfermedad; Substancia gris; Fragmentación; DNA; Apoptosis; Postmortem; Exploración; Hombre; In situ |
LO : | INIST-20953.354000071406360030 |
ID : | 99-0011802 |
Links to Exploration step
Pascal:99-0011802
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?</title>
<author><name sortKey="Kingsbury, A E" sort="Kingsbury, A E" uniqKey="Kingsbury A" first="A. E." last="Kingsbury">A. E. Kingsbury</name>
<affiliation><inist:fA14 i1="01"><s1>Parkinson's Disease Society Brain Research Centre, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mardsen, C D" sort="Mardsen, C D" uniqKey="Mardsen C" first="C. D." last="Mardsen">C. D. Mardsen</name>
<affiliation><inist:fA14 i1="02"><s1>Institute of Neurology, The National Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Foster, O J F" sort="Foster, O J F" uniqKey="Foster O" first="O. J. F." last="Foster">O. J. F. Foster</name>
<affiliation><inist:fA14 i1="01"><s1>Parkinson's Disease Society Brain Research Centre, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>St. George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0011802</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 99-0011802 INIST</idno>
<idno type="RBID">Pascal:99-0011802</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002F25</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?</title>
<author><name sortKey="Kingsbury, A E" sort="Kingsbury, A E" uniqKey="Kingsbury A" first="A. E." last="Kingsbury">A. E. Kingsbury</name>
<affiliation><inist:fA14 i1="01"><s1>Parkinson's Disease Society Brain Research Centre, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mardsen, C D" sort="Mardsen, C D" uniqKey="Mardsen C" first="C. D." last="Mardsen">C. D. Mardsen</name>
<affiliation><inist:fA14 i1="02"><s1>Institute of Neurology, The National Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Foster, O J F" sort="Foster, O J F" uniqKey="Foster O" first="O. J. F." last="Foster">O. J. F. Foster</name>
<affiliation><inist:fA14 i1="01"><s1>Parkinson's Disease Society Brain Research Centre, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>St. George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Apoptosis</term>
<term>DNA</term>
<term>Exploration</term>
<term>Fragmentation</term>
<term>Grey matter</term>
<term>Human</term>
<term>In situ</term>
<term>Parkinson disease</term>
<term>Postmortem</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Substance grise</term>
<term>Fragmentation</term>
<term>DNA</term>
<term>Apoptose</term>
<term>Postmortem</term>
<term>Exploration</term>
<term>Homme</term>
<term>In situ</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>KINGSBURY (A. E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MARDSEN (C. D.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FOSTER (O. J. F.)</s1>
</fA11>
<fA14 i1="01"><s1>Parkinson's Disease Society Brain Research Centre, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Institute of Neurology, The National Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>St. George's Hospital Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>877-884</s1>
</fA20>
<fA21><s1>1998</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000071406360030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0011802</s0>
</fA47>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Substance grise</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Grey matter</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Substancia gris</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Fragmentation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Fragmentation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Fragmentación</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>DNA</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>DNA</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>DNA</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Apoptose</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Apoptosis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Apoptosis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Postmortem</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Postmortem</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Postmortem</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Exploración</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>In situ</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>In situ</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>In situ</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Brain (vertebrata)</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>45</s5>
</fC07>
<fN21><s1>004</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 99-0011802 INIST</NO>
<ET>DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?</ET>
<AU>KINGSBURY (A. E.); MARDSEN (C. D.); FOSTER (O. J. F.)</AU>
<AF>Parkinson's Disease Society Brain Research Centre, Institute of Neurology/London/Royaume-Uni (1 aut., 3 aut.); Institute of Neurology, The National Hospital/London/Royaume-Uni (2 aut.); St. George's Hospital Medical School/London/Royaume-Uni (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 6; Pp. 877-884; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Substance grise; Fragmentation; DNA; Apoptose; Postmortem; Exploration; Homme; In situ</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Encéphale</FG>
<ED>Parkinson disease; Grey matter; Fragmentation; DNA; Apoptosis; Postmortem; Exploration; Human; In situ</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Brain (vertebrata)</EG>
<SD>Parkinson enfermedad; Substancia gris; Fragmentación; DNA; Apoptosis; Postmortem; Exploración; Hombre; In situ</SD>
<LO>INIST-20953.354000071406360030</LO>
<ID>99-0011802</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002F25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:99-0011802
|texte= DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | |